Young bone marrow transplants show promise in reversing Alzheimer’s symptoms in mice

FHS
June 4, 2024
4:39 am

Researchers found that young bone marrow transplants rejuvenate aging immune cells, reducing Alzheimer’s symptoms in mice models, suggesting a potential therapeutic approach for the disease.

Icahn lawsuit calls for millions in damages, removal of Illumina board members

A newly unsealed lawsuit filed by activist investor Carl Icahn alleges that Illumina board members ignored antitrust regulators when buying Grail for $8 billion, failed

October 22, 2023

Verve raises $148M via public stock offering, private placement with Eli Lilly (corrected)

After releasing the first-ever results of an in vivo base editing therapy in humans, Verve Therapeutics has priced a public offering of 12.5 million shares

November 30, 2023

Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds

The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR).

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.